Oncologix Tech Inc (OCLG)

[SPM555]

When it comes to these OTC mergers, the initial agreement is the easy part, it's the legal and technical stuff that takes a long time and offers up a ton of obstacles. Many times an agreement on paper never makes it to fruition because there's too much time and money involved to go through with the merger and consummate it. So all that in mind, there's clearly been a hold up here. The company hasn't updated the market with a PR since May. That was when they announced they would be merging with DNAgo.ai. The crickets ever since then have the market convinced the deal has fallen through or was an outright scam. My take is that these things take much longer quite often, but the signs point to this still being 'in progress'.

The last court date was in Dec and that was when Frank was discharged as custodian, so the merger is still a go based on that imo. The new site OCLGtech.com I stumbled across via random google searching for DD. It spells out all of the info the company (including both old and new entities) are working on, however it's clearly not yet meant to go live for visitors. Same goes with the IPOpg.ai link, with links to $OCLG. It looks like the info is all there, but if you dig in the site still isn't fully ready. While the sites are signs of life, they were never officially announced and if their IT guys were better the sites would be sandboxed and not visible to the public yet. That said, imo it's tipping us off that things are still a go.

My final comment is on the massive 250 page market report ($5,500 if you want the full version) which gives us a big fat mention in their summary. I highly recommend checking it out, but imo the fact that they included us implies they have done a level of DD on us based on the authority their presenting with their huge industry report. It's not a pump piece for penny stocks, it's a legit industry report that just so happens to mention this merger. Why? I'm guess they are familiar with DNAgo.ai or the officers involved, and deemed this a big deal. Just my take.

All this is to say, it's not surprising what I've posted isn't helping the share price yet. No one is paying attention. Yet. It's probably too early to get all excited yet because like I said the company is still officially radio silent and those websites look promising but not ready for action quite yet. I think this is getting close to part two with the company springing to life with updates, however that times isn't yet so patience is still the way, and buying the dip here imo is the play. The fact that this is so unloved, so beat down, and so thinly traded makes the potential here ridiculous. The market is pricing in no possibility of a successful merger, yet what I pointed out is a pretty compelling argument that there's indeed something brewing here. Just don't expect the market to catch on until the company is ready to make some noise.

Link to the hereditary genetic testing market report: https://www.emergenresearch.com/press-release/global-hereditary-genetic-testing-market